Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin

ClinicalTrials.gov ID: NCT04537923

Public ClinicalTrials.gov record NCT04537923. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 2:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the safety and efficacy of the study drug tirzepatide to insulin lispro (U100) three times a day in participants with type 2 diabetes that are already on insulin glargine (U100), with or without metformin.

Study identification

NCT ID
NCT04537923
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
1,428 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 19, 2020 (Actual)
Primary completion
Oct 11, 2022 (Actual)
Completion
Nov 1, 2022 (Actual)
Last update posted
Nov 2, 2023

2020 – 2022

United States locations

U.S. sites
40
U.S. states
17
U.S. cities
39
Facility City State ZIP Site status
Syed Research Consultants Llc Sheffield Alabama 35660 —
Valley Research Fresno California 93720 —
National Research Institute - Huntington Park Huntington Park California 90255 —
National Research Institute - Huntington Park Los Angeles California 90057 —
Valley Clinical Trials, Inc. Northridge California 91325 —
National Research Institute - Huntington Park Panorama City California 91402 —
National Research Institute (NRI) - Santa Ana Santa Ana California 92704 —
Encompass Clinical Research Spring Valley California 91978 —
University Clinical Investigators, Inc. Tustin California 92780 —
University of Colorado Aurora Colorado 80045 —
Excel Medical Clinical Trials Boca Raton Florida 33434 —
I R & Health Center, Inc. Hialeah Florida 33012 —
Sun Coast Clinical Research, Inc New Port Richey Florida 34652 —
South Broward Research Pembroke Pines Florida 33027 —
Metabolic Research Institute, Inc. West Palm Beach Florida 33401 —
Rocky Mountain Clinical Research Idaho Falls Idaho 83404 —
J H. Stroger Hosp of Cook Co Chicago Illinois 60612 —
Prairie Education and Research Cooperative Springfield Illinois 62711 —
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265 —
Capital Diabetes and Endocrine Associates Camp Springs Maryland 20746 —
MedStar Health Research Institute Hyattsville Maryland 20782 —
Endocrine and Metabolic Consultants Rockville Maryland 20852 —
Glacier View Research Institute - Endocrinology Kalispell Montana 59901 —
Southern Nh Diabetes and Endocrinology Nashua New Hampshire 03060 —
Albany Medical College Albany New York 12203 —
PMG Research of Wilmington Wilmington North Carolina 28401 —
Intend Research, LLC Norman Oklahoma 73069 —
Heritage Valley Medical Group, Inc. Beaver Pennsylvania 15009 —
Preferred Primary Care Physicians Uniontown Pennsylvania 15401 —
Tribe Clinical Research, LLC Greenville South Carolina 29607 —
Dallas Diabetes Research Center Dallas Texas 75230 —
Diabetes and Thyroid Center of Fort Worth Fort Worth Texas 76132 —
Juno Research Houston Texas 77040 —
Biopharma Informatic, LLC Houston Texas 77084 —
North Hills Medical Research North Richland Hills Texas 76180 —
Texas Diabetes & Endocrinology, P.A. Round Rock Texas 78681 —
Clinical Trials of Texas, Inc. San Antonio Texas 78229 —
Consano Clinical Research, LLC Shavano Park Texas 78231 —
Martin Diagnostic Clinic Tomball Texas 77375 —
Rainier Clinical Research Center Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 95 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04537923, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 2, 2023 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04537923 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →